Current Market Information

Last Trade Price (LTP) 21.30 Last Trade Date 04 August, 2026 Change -0.46 % Open Price 21.70 Day's Range 21.30 - 22.90     Total Trade 5 Total Volume 3750 Close Price 21.60 Yesterday Close Price 21.70 Market Capital in BDT (mn) 2242.231

Contact Information

Designation Name Mobile Number Email Chairman Mrs. Naim Fatema 01714073477 directorspl@gmail.com MD Dr. Md. Badrul Haque Rukan 01711920546 b.haquerukon58@gmail.com CFO Mr. Monjur Alam 01623618639 cfo.silcopharma@gmail.com Company Secretary Mr. Tingku Ranjan Sarker 01716394060 trt.tinku@gmail.com Office Address 41 Nurani, Bankalapara, Subid Bazar, Sylhet-3100 Phone : +88-0821-722241, 0821-2833054 Fax : Email : info@silcopharma.com Website : http://www.silcopharma.com/ Factory Address BSCIC Industrial Estate, Khadimnagor, Sylhet

Basic Information

Authorized Capital in BDT* (mn) 1,050.00 Paid-up Capital in BDT* (mn) 1,038.07 Face Value 10 Paid up Share 103807000     Market Lot 1 Sector PHARMA & CHEMICALS Market Category B

Other Information

Listing Year 2019 Debut Trade Date 13 June, 2019 Type of Instrument     52 Week's Range 12.00 - 22.80 Year End 30 June Reserve / Surplus(mn) 1351.81 Remarks Note

Share Holding Percentage

Sponsor/Director Govt. Institute Foreign Public As on 30-Apr, 2026 35.27254 0 16.46186 0 48.2656 As on 31-Mar, 2026 35.27254 0 17.61704 0 47.11042 As on 28-Feb, 2026 35.27254 0 16.50058 0 48.22688 As on 30-Jun, 2026 (year ended) 35.27254 0 19.65985 0 45.06761     Remarks Note     Credit Rating Status Credit Rating Year Long Term Short Term Outlook Validity Date Credit Rating Company Dec 29, 2024 BBB ST-3 Stable Dec 28, 2025 Alpha Credit Rating Limited         Half Year End (HY) Information  202512 HY Net Turnover(mn)  226.16 HY Net Profit after tax(mn)  27.52 HY EPS  0.27  AGM Information   AGM Date  19 January, 2026 Record Date  15 December, 2025 Dividend(%)  1.10(Cash for all shareholders excluding directors-June 2025) Bonus Issue  10%-2019

   

Financial Performance
Performance Year	Basic EPS Based On		Basic EPS (restated) Based On		Net Asset Value Per Share	Restated Net Asset Value Per Share	Net Profit After Tax(mn)		% Dividend	% Dividend Yield
	Continuous operations	Including Extra-Ordinary Income	Continuous operations	Including Extra-Ordinary Income			Continuous operations	Including Extra-Ordinary Income
2025	0.41	0	0	0	23.02	0	42.65	0	1.10%C	0.74
2024	0.44	0	0	0	22.66	0	45.88	0	1%C	0.57
2023	0.67	0	0	0	22.35	0	69.22	0	3%C	1.24
2022	0.81	0	0	0	21.95	0	84.45	0	5%C	1.89
2021	0.82	0	0	0	21.85	0	84.65	0	10%C	3.83

Financial Statements
Quarterly Financial Statement	http://www.silcopharma.com/quarterly-reports/
Price Sensitive Information	http://www.silcopharma.com/price-sensitive-information/

Close Price and Traded Volume Graph
Click here to view 1 month graph	Click here to view 3 month graph	Click here to view 6 month graph
Form	To